We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Achieve predictable workflows and reduce variability with CTGrade interleukins and growth factors.
The predictability and performance of CTGrade interleukins and growth factors help cell and gene therapy developers accelerate delivery of life-changing therapies to market.
The biological activity of CTGrade interleukins and growth factors is standardized to WHO International standards, where applicable, providing cell and gene therapy developers consistent, lot-to-lot biological activity and performance.
CTGrade products are produced from E. coli and are manufactured in a facility that does not use or process beta-lactam containing materials. No animal- or human-derived materials were used during manufacturing or as ingredients. These products are manufactured, tested, and released in an ISO 9001:2015 certified facility following cGMP practices.
Shenandoah CTGrade Recombinant Proteins
Making the right decision the first time
When designing robust cell and gene therapy processes, making the right decision the first time is critical for delivering therapies to market. CTGrade interleukins and growth factors from Shenandoah, a FUJIFILM Irvine Scientific company, are formulated to reduce variability and ensure predictable workflow performance in the proliferation and differentiation of T cells, natural killer (NK) cells, B cells, and chimeric antigen receptor (CAR-T) cells. Together with our unparalleled regulatory guidance and assurance of expected performance, CTGrade interleukins and growth factors help cell and gene therapy developers proactively deliver the full promise of their discoveries.